Biologically relevant chemical space navigator: From patent and structure-activity relationship analysis to library acquisition and design

Journal of Chemical Information and Modeling

Volumn 52, Issue 12, 2012, Pages 3123-3137

  Rabal, Obdulia ^a   Oyarzabal, Julen ^a  

^a UNIVERSITY OF NAVARRA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

LIGANDS; PATENTS AND INVENTIONS; STRUCTURES (BUILT OBJECTS);

CHEMICAL SPACE; CONGENERIC SERIES; DRUG DISCOVERY PROCESS; LIBRARY ACQUISITIONS; LIGAND-RECEPTOR INTERACTIONS; NAVIGATION STRATEGIES; STRUCTURE-ACTIVITY RELATIONSHIPS; VISUALIZATION TOOLS;

CHEMICAL ANALYSIS;

DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ARTICLE; CHEMISTRY; DRUG DATABASE; DRUG DESIGN; PATENT; STRUCTURE ACTIVITY RELATION;

DATABASES, PHARMACEUTICAL; DRUG DESIGN; INDICATORS AND REAGENTS; PATENTS AS TOPIC; STRUCTURE-ACTIVITY RELATIONSHIP;

EID: 84871554474     PISSN: 15499596     EISSN: 1549960X     Source Type: Journal    
DOI: 10.1021/ci3004539     Document Type: Article

References (40)

1. Kirkpatrick, P.; Ellis, C. Chemical Space Nature 2004, 432, 823
2. Hert, J.; Irwin, J. J.; Laggner, C.; Keiser, M. J.; Shoichet, B. K. Quantifying Biogenic Bias in Screening Libraries Nat. Chem. Biol. 2009, 5, 479-483
3. Wetzel, S.; Bon, R. S.; Kumar, K.; Waldmann, H. Biology Oriented Synthesis Angew. Chem., Int. Ed. 2011, 50, 10800-10826
4. Hartenfeller, M.; Eberle, M.; Meier, P.; Nieto-Oberhuber, C.; Altmann, K. H.; Schneider, G.; Jacoby, E.; Renner, S. Probing the Bioactivity-Relevant Chemical Space of Robust Reactions and Common Molecular Building Blocks J. Chem. Inf. Model. 2012, 52, 1167-1178
5. Dobson, C. M. Chemical Space and Biology Nature 2004, 432, 824-828
6. Rabal, O.; Oyarzabal, J. Using Novel Descriptor Accounting for Ligand-Receptor Interactions To Define and Visually Explore Biologically Relevant Chemical Space J. Chem. Inf. Model. 2012, 52, 1086-1102
7. Wetzel, S.; Klein, K.; Renner, S.; Rauh, D.; Oprea, T. I.; Mutzel, P.; Waldmann, H. Interactive Exploration of Chemical Space with Scaffold Hunter Nat. Chem. Biol. 2009, 5, 581-583
8. Agrafiotis, D. K.; Wiener, J. J. M. Scaffold Explorer: An Interactive Tool for Organizing and Mining Structure-Activity Data Spanning Multiple Chemotypes J. Med. Chem. 2010, 53, 5002-5011
9. Gupta-Ostermann, D.; Hu, Y.; Bajorath, J. Introducing the LASSO Graph for Compound Data Set Representation and Structure-Activity Relationship Analysis J. Med. Chem. 2012, 55, 5546-5553
10. Kettle, J. G.; Ward, R. A. Toward the Comprehensive Systematic Enumeration and Synthesis of Novel Kinase Inhibitors Based on a 4-Anilinoquinazoline Binding Mode J. Chem. Inf. Model. 2010, 50, 525-533
11. Ward, R. A.; Kettle, J. G. Systematic Enumeration of Heteroaromatic Ring Systems as Reagents for Use in Medicinal Chemistry J. Med. Chem. 2011, 54, 4670-4677
12. Bajorath, J.; Peltason, L.; Wawer, M.; Guha, R.; Lajiness, M. S.; Van Drie, J. H. Navigating Structure-Activity Landscapes Drug Discovery Today 2009, 14, 698-705
13. Wassermann, A. M.; Wawer, M.; Bajorath, J. Activity Landscape Representations for Structure-Activity Relationship Analysis J. Med. Chem. 2010, 53, 8209-8223
14. Stumpfe, D.; Bajorath, J. Methods for SAR Visualization RSC Adv. 2012, 2, 369-378
15. Agrafiotis, D. K.; Shemanarev, M.; Connolly, P. J.; Farnum, M.; Lobanov, V. S. SAR Maps: A New SAR Visualization Technique for Medicinal Chemists J. Med. Chem. 2007, 50, 5926-5937
16. Wassermann, A. M.; Peltason, L.; Bajorath, J. Computational Analysis of Multi-Target Structure-Activity Relationships To Derive Preference Orders for Chemical Modifications toward Target Selectivity ChemMedChem 2010, 5, 847-858
17. Wassermann, A. M.; Bajorath, J. Directed R-group Combination Graph: A Methodology to Uncover Structure-Activity Relationship Patterns in Series of Analogues J. Med. Chem. 2012, 55, 1215-1226
18. Wawer, M.; Lounkine, E.; Wassermann, A. M.; Bajorath, J. Data Structures and Computational Tools for the Extraction of SAR Information From Large Compound Sets Drug Discovery Today 2010, 15, 630-639
19. Tyrchan, C.; Boström, J.; Giordanetto, F.; Winter, J.; Muresan, S. Exploiting Structural Information in Patent Specifications for Key Compound Prediction J. Chem. Inf. Model. 2012, 52, 1480-1489
20. Hattori, K.; Wakabayashi, H.; Tamaki, K. Predicting Key Example Compounds in Competitors' Patent Applications Using Structural Information Alone J. Chem. Inf. Model. 2008, 48, 135-142
21. Oyarzabal, J.; Howe, T.; Alcazar, J.; Andres, J. I.; Alvarez, R. M.; Dautzenberg, F.; Iturrino, L.; Martinez, S.; Van der Linden, I. Novel Approach for Chemotype Hopping Based on Annotated Databases of Chemically Feasible Fragments and a Prospective Case Study: New Melanin Concentrating Hormone Antagonists J. Med. Chem. 2009, 52, 2076-2089
22. Saluste, G.; Albarran, M. A.; Alvarez, R. M.; Rabal, O.; Ortega, M. A.; Blanco, C.; Kurz, G.; Salgado, A.; Pevarello, P.; Bischoff, J. R.; Pastor, J.; Oyarzabal, J. Fragment-Hopping-Based Discovery of a Novel Chemical Series of Protooncogene PIM-1 Kinase Inhibitors PLoS One 2012, 7, e45964
23. Rabal, O.; Urbano-Cuadrado, M.; Oyarzabal, J. Computational Medicinal Chemistry in Fragment-Based Drug Discovery: What, How and When Future Med. Chem. 2011, 3, 95-134
24. Pipeline Pilot, version 8.5; Accelrys, Inc.: San Diego, CA, 2011.
25. Irwin, J. J.; Sterling, T.; Mysinger, M. M.; Bolstad, E. S.; Coleman, R. G. ZINC-A Free Tool to Discover Chemistry for Biology J. Chem. Inf. Model. 2012, 52, 1757-1768
26. Accelrys Available Chemicals Directory (ACD); Accelrys, Inc.: San Diego, CA, 2012.
27. Kinase Knowledgebase (KKB); Eidogen-Sertanty, Inc.: San Diego, CA, 2011.
28. Bold, G.; Frei, J.; Traxler, P.; Altmann, K. H.; Mett, H.; Stover, D. R.; Wood, J. M. Phthalazines with angiogenesis inhibiting activity. PCT WO 98/35958 (A1), August 20, 1998. 113 pp.
29. Bold, G.; Dawson, K. J.; Frei, J.; Heng, R.; Manley, P. W.; Wietfeld, B.; Wood, J. M. Phthalazine derivatives for treating inflammatory diseases. PCT WO 00/59509 (A1), October 12, 2000. 127 pp.
30. Bold, G.; Manley, P. W. Phthalazines with angiogenesis inhibiting activity. PCT WO 02/090346 (A1), November 14, 2002. 67 pp.
31. Cee, V. J.; Deak, H. L.; Du, B.; Geuns-Meyer, S. D.; Hodous, B. L.; Nguyen, H. N.; Olivieri, P. R.; Patel, V. F.; Romero, K.; Schenkel, L. Aurora Kinase Modulators and Method of Use. PCT WO 2007/087276 (A1), January 22, 2007.189 pp.
32. Cee, V. J.; Deak, H. L.; Geuns-Meyer, S. D.; Du, B.; Hodous, B. L.; Martin, M. W.; Nguyen, H. N.; Olivieri, P. R.; Panter, K.; Romero, K.; Schenkel, L.; White, R. Aurora Kinase Modulators and Method of Use. PCT WO 2008/124083 (A2), October 16, 2008. 211 pp.
33. White, R.; Human, J. B. Aurora Kinase Modulators and Method of Use. PCT WO 2009/117157 (A1), September 24, 2009. 94 pp.
34. Deak, H. L.; Geuns-Meyer, S. D.; Human, J. B.; Martin, M.; Marx, I. Aurora Kinase Modulators and Method of Use. PCT WO 2010/017240 (A2), February 11, 2010. 77 pp.
35. Wood, J. M.; Bold, G.; Buchdunger, E.; Cozens, R.; Ferrari, S.; Frei, J.; Hofmann, F.; Mestan, J.; Mett, H.; O'Reilly, T.; Persohn, E.; Rösel, J.; Schnell, C.; Stover, D.; Theuer, A.; Towbin, H.; Wenger, F.; Woods-Cook, K.; Menrad, A.; Siemeister, G.; Schirner, M.; Thierauch, K. H.; Schneider, M. R.; Drevs, J.; Martiny-Baron, G.; Totzke, F. PTK787/ZK 222584, a Novel and Potent Inhibitor of Vascular Endothelial Growth Factor Receptor Tyrosine Kinases, Impairs Vascular Endothelial Growth Factor-induced Responses and Tumor Growth after Oral Administration Cancer Res. 2000, 60, 2178-2189
36. Payton, M.; Bush, T. L.; Chung, G.; Ziegler, B.; Eden, P.; McElroy, P.; Ross, S.; Cee, V. J.; Deak, H. L.; Hodous, B. L.; Nguyen, H. N.; Olivieri, P. R.; Romero, K.; Schenkel, L. B.; Bak, A.; Stanton, M.; Dussault, I.; Patel, V. F.; Geuns-Meyer, S.; Radinsky, R.; Kendall, R. L. Preclinical Evaluation of AMG 900, a Novel Potent and Highly Selective Pan-Aurora Kinase Inhibitor with Activity in Taxane-Resistant Tumor Cell Lines Cancer Res. 2010, 70, 9846-9854
37. Scifinder, web version; Chemical Abstracts Service: Columbus, OH, 2012.
38. Cee, V. J.; Schenkel, L. B.; Hodous, B. L.; Deak, H. L.; Nguyen, H. N.; Olivieri, P. R.; Romero, K.; Bak, A.; Be, X.; Bellon, S.; Bush, T. L.; Cheng, A. C.; Chung, G.; Coats, S.; Eden, P. M.; Hanestad, K.; Gallant, P. L.; Gu, Y.; Huang, X.; Kendall, R. L.; Lin, M. H.; Morrison, M. J.; Patel, V. F.; Radinsky, R.; Rose, P. E.; Ross, S.; Sun, J. R.; Tang, J.; Zhao, H.; Payton, M.; Geuns-Meyer, S. D. Discovery of a Potent, Selective, and Orally Bioavailable Pyridinyl-Pyrimidine Phthalazine Aurora Kinase Inhibitor J. Med. Chem. 2010, 53, 6368-6377
39. ChEMBL; European Bioinformatics Institute (EBI): Cambridge, UK, 2010. http://www.ebi.ac.uk/chembl (accessed July 31, 2012).
40. PubChem Compound Database; National Center for Biotechnology Information (NCBI). http://pubchem.ncbi.nlm.nih.gov/ (accessed July 31, 2012).